CETP inhibitor (Suzhou Kintor Pharmaceuticals)

N/A

Report date: 2025/03/18 18:04:45
NME

Base Information

Drug NameCETP inhibitor (Suzhou Kintor Pharmaceuticals)
Drug Alias Namecardiovascular disease drug (Suzhou Kintor Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A